Context Therapeutics Investor Presentation Deck

Experienced Leadership Team Martin Lehr CEO and Director Chris Beck, MBA SVP Operations Tarek Sahmoud, MD, PhD Chief Medical Officer 22 Context Therapeutics Inc. - Sept. 2022 Praesidia OLOGICS Cure Duchenne OSAGE UNIVERSITY PARTNERS Galera Therape, Shire MERCK NOVARTIS H3 Bowde Celgene Jennifer Minai, CPA Chief Financial Officer Alex Levit, Esq Chief Legal Officer Priya Marreddy, MS VP Clinical Operations MILLENDO THERAPEUTICS parexel, EY optinose teva ReedSmith Spark teva PRA Health Sciences Corporate Focus on Execution . • Experienced team with deep oncology experience • Our CMO led the clinical development of multiple blockbuster drugs for female cancers, including Kisqali, Arimidex, and Afinitor • Our management team is supported by a Board with strong public company operating and governance experience

View entire presentation